cytosine has been researched along with Lymphoma in 18 studies
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
Excerpt | Relevance | Reference |
---|---|---|
" Importantly, cytosine hypermethylation in the 5'-long terminal repeat (LTR) U3 and R regions was associated with true latency in the lymphoma-derived B-cell line L267 but not with defective latency in YR2 cells." | 7.76 | DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct inhibition of cAMP-responsive element (CRE)-binding protein/CRE modulator/activation transcription ( Blazkova, J; Burny, A; Calomme, C; Cardona, C; Colin, L; Dekoninck, A; Guiguen, A; Hirsch, I; Kettmann, R; Merimi, M; Nguyên, TL; Nuttinck, M; Pierard, V; Portetelle, D; Rohr, O; Twizere, JC; Van Driessche, B; Van Lint, C; Vanhulle, C; Vierendeel, V; Wijmeersch, G, 2010) |
" Future studies will be needed to address modified dosing according to emerging pharmacokinetic and pharmacodynamic data and combination therapy which may lead to improved clinical benefit for troxacitabine in hematologic malignancies." | 6.73 | A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma. ( Baccarani, M; Belanger, R; Ben-Yehuda, D; Caballero, D; Coiffier, B; Facon, T; Fanin, R; Giles, F; Gregory, SA; Panwalkar, A; Vose, JM, 2007) |
" Nucleoside analogs in development for non-Hodgkin's lymphoma (NHL) include clofarabine, troxacitabine, and bendamustine, a hybrid of an alkylating nitrogen mustard group and a purine-like benzimidazole, with demonstrated activity in NHL." | 4.81 | Hematologic malignancies: new developments and future treatments. ( Cheson, BD, 2002) |
" Importantly, cytosine hypermethylation in the 5'-long terminal repeat (LTR) U3 and R regions was associated with true latency in the lymphoma-derived B-cell line L267 but not with defective latency in YR2 cells." | 3.76 | DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct inhibition of cAMP-responsive element (CRE)-binding protein/CRE modulator/activation transcription ( Blazkova, J; Burny, A; Calomme, C; Cardona, C; Colin, L; Dekoninck, A; Guiguen, A; Hirsch, I; Kettmann, R; Merimi, M; Nguyên, TL; Nuttinck, M; Pierard, V; Portetelle, D; Rohr, O; Twizere, JC; Van Driessche, B; Van Lint, C; Vanhulle, C; Vierendeel, V; Wijmeersch, G, 2010) |
"We found that several major chromosomal fragile sites in human lymphomas, including the bcl-2 major breakpoint region, bcl-1 major translocation cluster, and c-Myc exon 1-intron 1 boundary, contain distinctive sequences of consecutive cytosines exhibiting a high degree of reactivity with the structure-specific chemical probe bisulfite." | 3.75 | Conformational variants of duplex DNA correlated with cytosine-rich chromosomal fragile sites. ( Engelhart, AE; Hatmal, MM; Haworth, IS; Houston, SI; Hud, NV; Lieber, MR; Tsai, AG, 2009) |
"The extent of methylation of DNA during the transition of cells from exponential phase of growth to the saturation density has been studied in cultured L5178Y mouse lymphoma cells by the comparison of the degree of 5-methylcytosine formation and the stability of this preformed base in various periods of their growth." | 3.66 | DNA methylation in various growth phases of cultured L5178Y murine lymphoblasts. ( Kornacka, L; Malec, J; Sawecka, J, 1979) |
" Future studies will be needed to address modified dosing according to emerging pharmacokinetic and pharmacodynamic data and combination therapy which may lead to improved clinical benefit for troxacitabine in hematologic malignancies." | 2.73 | A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma. ( Baccarani, M; Belanger, R; Ben-Yehuda, D; Caballero, D; Coiffier, B; Facon, T; Fanin, R; Giles, F; Gregory, SA; Panwalkar, A; Vose, JM, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (50.00) | 18.7374 |
1990's | 2 (11.11) | 18.2507 |
2000's | 4 (22.22) | 29.6817 |
2010's | 3 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frobel, J | 1 |
Božić, T | 1 |
Lenz, M | 1 |
Uciechowski, P | 1 |
Han, Y | 1 |
Herwartz, R | 1 |
Strathmann, K | 1 |
Isfort, S | 1 |
Panse, J | 1 |
Esser, A | 1 |
Birkhofer, C | 1 |
Gerstenmaier, U | 1 |
Kraus, T | 1 |
Rink, L | 1 |
Koschmieder, S | 1 |
Wagner, W | 1 |
Tsai, AG | 1 |
Engelhart, AE | 1 |
Hatmal, MM | 1 |
Houston, SI | 1 |
Hud, NV | 1 |
Haworth, IS | 1 |
Lieber, MR | 1 |
Pierard, V | 1 |
Guiguen, A | 1 |
Colin, L | 1 |
Wijmeersch, G | 1 |
Vanhulle, C | 1 |
Van Driessche, B | 1 |
Dekoninck, A | 1 |
Blazkova, J | 1 |
Cardona, C | 1 |
Merimi, M | 1 |
Vierendeel, V | 1 |
Calomme, C | 1 |
Nguyên, TL | 1 |
Nuttinck, M | 1 |
Twizere, JC | 1 |
Kettmann, R | 1 |
Portetelle, D | 1 |
Burny, A | 1 |
Hirsch, I | 1 |
Rohr, O | 1 |
Van Lint, C | 1 |
Ruozi, B | 1 |
Riva, G | 1 |
Belletti, D | 1 |
Tosi, G | 1 |
Forni, F | 1 |
Mucci, A | 1 |
Barozzi, P | 1 |
Luppi, M | 2 |
Vandelli, MA | 1 |
Cheson, BD | 1 |
MAUTNER, HG | 1 |
CHU, SH | 1 |
JAFFE, JJ | 1 |
SARTORELLI, AC | 1 |
EVANS, JS | 1 |
MUSSER, EA | 1 |
BOSTWICK, L | 1 |
MENGEL, GD | 1 |
Halfdanarson, TR | 1 |
Markovic, SN | 1 |
Kalokhe, U | 1 |
Vose, JM | 1 |
Panwalkar, A | 1 |
Belanger, R | 1 |
Coiffier, B | 1 |
Baccarani, M | 1 |
Gregory, SA | 1 |
Facon, T | 1 |
Fanin, R | 1 |
Caballero, D | 1 |
Ben-Yehuda, D | 1 |
Giles, F | 1 |
Burchenal, JH | 1 |
Romanov, GA | 1 |
Vanyushin, BF | 1 |
Mangues, R | 1 |
Schwartz, S | 1 |
Seidman, I | 1 |
Pellicer, A | 1 |
Gan, J | 1 |
Zhang, YL | 1 |
Carter, KB | 1 |
Cauthron, RD | 1 |
Steinberg, RA | 1 |
Sutow, WW | 1 |
Sullivan, MP | 1 |
Sawecka, J | 1 |
Kornacka, L | 1 |
Malec, J | 1 |
Sneller, MC | 1 |
Gunter, KC | 1 |
Müller, WE | 1 |
Yamazaki, Z | 1 |
Zahn, RK | 1 |
Fairley, GH | 1 |
2 reviews available for cytosine and Lymphoma
Article | Year |
---|---|
Hematologic malignancies: new developments and future treatments.
Topics: Adenine Nucleotides; Alemtuzumab; Alkaloids; Antibodies, Monoclonal; Antibodies, Monoclonal, Humaniz | 2002 |
Combination chemotherapy in malignant diseases.
Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosin | 1971 |
1 trial available for cytosine and Lymphoma
Article | Year |
---|---|
A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma.
Topics: Adult; Aged; Antineoplastic Agents; Cytosine; Dioxolanes; Dose-Response Relationship, Drug; Drug Res | 2007 |
15 other studies available for cytosine and Lymphoma
Article | Year |
---|---|
Leukocyte Counts Based on DNA Methylation at Individual Cytosines.
Topics: Blood Preservation; Carrier Proteins; CpG Islands; Cytosine; DNA Methylation; Humans; Leukocyte Coun | 2018 |
Conformational variants of duplex DNA correlated with cytosine-rich chromosomal fragile sites.
Topics: Chromosome Fragility; Chromosomes, Human; Circular Dichroism; Crystallography, X-Ray; Cytosine; DNA; | 2009 |
DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct inhibition of cAMP-responsive element (CRE)-binding protein/CRE modulator/activation transcription
Topics: Activating Transcription Factor 1; B-Lymphocytes; Chromatin; Cyclic AMP; Cyclic AMP Response Element | 2010 |
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma.
Topics: Antiviral Agents; Cell Line, Tumor; Cidofovir; Cytosine; Flow Cytometry; Humans; Liposomes; Lymphoma | 2010 |
THE SYNTHESIS AND ANTINEOPLASTIC PROPERTIES OF SELENOGUANINE, SELENOCYTOSINE AND RELATED COMPOUNDS.
Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Cytosine; Guanine; Leukemia L1210; Lympho | 1963 |
THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE ON MURINE NEOPLASMS.
Topics: Animals; Anti-Bacterial Agents; Antibodies; Antineoplastic Agents; Blood Cells; Carcinoma, Ehrlich T | 1964 |
A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy.
Topics: Aged; Antineoplastic Agents; Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; HIV S | 2006 |
Geographic chemotherapy--Burkitt's tumor as a stalking horse for leukemia: presidential address.
Topics: Adult; Africa; Antineoplastic Agents; Child; Cytosine; Female; Follow-Up Studies; Geography; Humans; | 1966 |
Methylation of reiterated sequences in mammalian DNAs. Effects of the tissue type, age, malignancy and hormonal induction.
Topics: 5-Methylcytosine; Animals; Carcinoma, Ehrlich Tumor; Cattle; Cattle Diseases; Cytosine; DNA; DNA, Ne | 1981 |
Promoter demethylation in MMTV/N-rasN transgenic mice required for transgene expression and tumorigenesis.
Topics: 5-Methylcytosine; Age Factors; Animals; Cytosine; Gene Expression; Gene Expression Regulation, Neopl | 1995 |
On the spontaneous mutability of CpG sites in cultured S49 mouse lymphoma cells.
Topics: 5-Methylcytosine; Animals; Arginine; Azacitidine; Cytosine; Dinucleoside Phosphates; DNA Methylation | 1999 |
Childhood cancer: the improving prognosis.
Topics: Asparaginase; Child; Cyclophosphamide; Cytosine; Daunorubicin; Doxorubicin; Drug Therapy, Combinatio | 1976 |
DNA methylation in various growth phases of cultured L5178Y murine lymphoblasts.
Topics: Animals; Cell Division; Cells, Cultured; Cytosine; DNA, Neoplasm; Leukemia, Experimental; Lymphoma; | 1979 |
DNA methylation alters chromatin structure and regulates Thy-1 expression in EL-4 T cells.
Topics: 5-Methylcytosine; Animals; Antigens, Surface; Azacitidine; Cell Line; Chromatin; Cytosine; Decitabin | 1987 |
[Influence of arabinofuranosylcytosine on DNA synthesis in mouse lymphoma cells and in sea-urchin embryos].
Topics: Animals; Arabinose; Cytosine; Deoxyribonucleases; DNA; DNA, Neoplasm; Embryo, Mammalian; Embryo, Non | 1972 |